HRP20041137B1 - Indolni, azaindolni i srodni heterocikliäśni 4-alkenil piperidinski amidi - Google Patents

Indolni, azaindolni i srodni heterocikliäśni 4-alkenil piperidinski amidi

Info

Publication number
HRP20041137B1
HRP20041137B1 HRP20041137AA HRP20041137A HRP20041137B1 HR P20041137 B1 HRP20041137 B1 HR P20041137B1 HR P20041137A A HRP20041137A A HR P20041137AA HR P20041137 A HRP20041137 A HR P20041137A HR P20041137 B1 HRP20041137 B1 HR P20041137B1
Authority
HR
Croatia
Prior art keywords
azaindole
indole
present
related heterocyclic
piperidine amides
Prior art date
Application number
HRP20041137AA
Other languages
English (en)
Croatian (hr)
Inventor
Carol Bachand
Clint A. James
Nicholas A. Meanwell
Daniel H. Deon
John F. Kadow
Zhilei Qiu
Edward H. Ruediger
Tao Wang
Kap-Sun Yeung
Zhongxing Zhang
Zhiwei Yin
Original Assignee
Bristol-Myers Squibb Company A Delaware (Usa) Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32312411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20041137(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol-Myers Squibb Company A Delaware (Usa) Corporation filed Critical Bristol-Myers Squibb Company A Delaware (Usa) Corporation
Publication of HRP20041137A2 publication Critical patent/HRP20041137A2/xx
Publication of HRP20041137B1 publication Critical patent/HRP20041137B1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HRP20041137AA 2002-05-28 2003-04-30 Indolni, azaindolni i srodni heterocikliäśni 4-alkenil piperidinski amidi HRP20041137B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38350902P 2002-05-28 2002-05-28
PCT/US2003/013324 WO2004043337A2 (en) 2002-05-28 2003-04-30 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides

Publications (2)

Publication Number Publication Date
HRP20041137A2 HRP20041137A2 (en) 2005-06-30
HRP20041137B1 true HRP20041137B1 (hr) 2014-11-21

Family

ID=32312411

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20041137AA HRP20041137B1 (hr) 2002-05-28 2003-04-30 Indolni, azaindolni i srodni heterocikliäśni 4-alkenil piperidinski amidi

Country Status (31)

Country Link
US (1) US20040063744A1 (enExample)
EP (1) EP1513832B1 (enExample)
JP (1) JP4446889B2 (enExample)
KR (1) KR101001811B1 (enExample)
CN (1) CN100528866C (enExample)
AR (1) AR040230A1 (enExample)
AU (1) AU2003301958B2 (enExample)
BR (2) BR0311541A (enExample)
CA (1) CA2487542C (enExample)
CL (1) CL2003001087A1 (enExample)
CO (1) CO5631440A2 (enExample)
DK (1) DK1513832T3 (enExample)
ES (1) ES2460728T3 (enExample)
GE (1) GEP20074152B (enExample)
HR (1) HRP20041137B1 (enExample)
IL (1) IL165200A (enExample)
IS (1) IS2945B (enExample)
MX (1) MXPA04011670A (enExample)
MY (1) MY139058A (enExample)
NO (1) NO329691B1 (enExample)
NZ (1) NZ536661A (enExample)
PE (1) PE20040526A1 (enExample)
PL (1) PL216388B1 (enExample)
PT (1) PT1513832E (enExample)
RS (1) RS53021B (enExample)
RU (1) RU2323934C2 (enExample)
SI (1) SI1513832T1 (enExample)
TW (1) TWI310381B (enExample)
UA (1) UA79470C2 (enExample)
WO (1) WO2004043337A2 (enExample)
ZA (1) ZA200409504B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US20040110785A1 (en) * 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US20050075364A1 (en) * 2003-07-01 2005-04-07 Kap-Sun Yeung Indole, azaindole and related heterocyclic N-substituted piperazine derivatives
US20050124623A1 (en) 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
US7087610B2 (en) * 2004-06-03 2006-08-08 Bristol-Myers Squibb Company Benzothiazole antiviral agents
EP1753764B1 (en) 2004-06-09 2008-10-29 Glaxo Group Limited Pyrrolopyridine derivatives
US20060100432A1 (en) * 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US20060100209A1 (en) * 2004-11-09 2006-05-11 Chong-Hui Gu Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US7601715B2 (en) * 2005-06-22 2009-10-13 Bristol-Myers Squibb Company Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
CA2618165A1 (en) * 2005-08-09 2007-02-15 Glaxo Group Limited Imidazopyridine derivatives as cannabinoid receptor ligands
US7851476B2 (en) * 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) * 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
US7504399B2 (en) * 2006-06-08 2009-03-17 Bristol-Meyers Squibb Company Piperazine enamines as antiviral agents
US7572810B2 (en) * 2006-06-08 2009-08-11 Bristol-Myers Squibb Company Alkene piperidine derivatives as antiviral agents
TWI443090B (zh) * 2007-05-25 2014-07-01 Abbvie Deutschland 作為代謝性麩胺酸受體２（ｍｇｌｕ２ 受體）之正向調節劑之雜環化合物
WO2009011912A1 (en) * 2007-07-18 2009-01-22 Bristol-Myers Squibb Company A composition for treating hiv comprising virus-like particles
WO2009158394A1 (en) * 2008-06-25 2009-12-30 Bristol-Myers Squibb Company Diketo azolopiperidines and azolopiperazines as anti-hiv agents
CN102076686B (zh) * 2008-06-25 2013-03-06 百时美施贵宝公司 作为hiv附着抑制剂的二酮哌啶衍生物
ES2383149T3 (es) * 2008-09-04 2012-06-18 Bristol-Myers Squibb Company Composicion farmacéutica estable para la administración optimizada de un inhibidor de la unión del VIH
CN104856991A (zh) * 2009-02-27 2015-08-26 西佳技术公司 用于治疗和预防登革热病毒感染的噻吩并吡啶衍生物
ES2436566T3 (es) 2009-04-02 2014-01-03 Shionogi & Co., Ltd. Compuestos de acrilamida y utilización de los mismos
EP2308866A1 (de) 2009-10-09 2011-04-13 Bayer CropScience AG Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide
US8450361B2 (en) * 2010-08-06 2013-05-28 Bristol-Myers Squibb Company Substituted indole and azaindole oxoacetyl piperazinamide derivatives
ES2585396T3 (es) 2010-12-02 2016-10-05 VIIV Healthcare UK (No.5) Limited Alquilamidas como inhibidores de la unión del VIH
EP2696937B1 (en) 2011-04-12 2017-05-17 VIIV Healthcare UK (No.5) Limited Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
ES2616268T3 (es) 2011-08-29 2017-06-12 VIIV Healthcare UK (No.5) Limited Derivados condensados de diamina bicíclica como inhibidores de la unión de VIH
ES2609579T3 (es) 2011-08-29 2017-04-21 VIIV Healthcare UK (No.5) Limited Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH
BR112014019289A8 (pt) * 2012-02-08 2017-07-11 Bristol Myers Squibb Co Métodos para a preparação do composto de prome-dicamento de piperazina inibidor da ligação do hiv
US9193725B2 (en) 2012-03-14 2015-11-24 Bristol-Meyers Squibb Company Cyclic hydrazine derivatives as HIV attachment inhibitors
ES2616492T3 (es) * 2012-08-09 2017-06-13 VIIV Healthcare UK (No.5) Limited Derivados de piperidina amida como inhibidores de la fijación del VIH
ES2616432T3 (es) * 2012-08-09 2017-06-13 VIIV Healthcare UK (No.5) Limited Derivados de alquenos tricíclicos como inhibidores de la unión del VIH
WO2017112576A1 (en) * 2015-12-21 2017-06-29 Dow Global Technologies Llc Methods for external base-free suzuki couplings
CN108059611A (zh) * 2018-01-22 2018-05-22 济南舜景医药科技有限公司 一种用于治疗心率不齐药物中间体的合成方法
CN109053575A (zh) * 2018-08-24 2018-12-21 遵义医学院 3-环丙基-1-甲基-1h-吡唑-4-甲醛的制备工艺

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024350A1 (en) * 1995-12-27 1997-07-10 Janssen Pharmaceutica N.V. N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
WO1998028292A1 (en) * 1996-12-23 1998-07-02 Smithkline Beecham Corporation Novel piperidine containing compounds
WO2001062255A1 (en) * 2000-02-22 2001-08-30 Bristol-Myers Squibb Company Antiviral azaindole derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023265A (en) * 1990-06-01 1991-06-11 Schering Corporation Substituted 1-H-pyrrolopyridine-3-carboxamides
US5124327A (en) * 1991-09-06 1992-06-23 Merck & Co., Inc. HIV reverse transcriptase
US5424329A (en) * 1993-08-18 1995-06-13 Warner-Lambert Company Indole-2-carboxamides as inhibitors of cell adhesion
TW548271B (en) * 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
US6469006B1 (en) * 1999-06-15 2002-10-22 Bristol-Myers Squibb Company Antiviral indoleoxoacetyl piperazine derivatives
US6476034B2 (en) * 2000-02-22 2002-11-05 Bristol-Myers Squibb Company Antiviral azaindole derivatives
US6573262B2 (en) * 2000-07-10 2003-06-03 Bristol-Myers Sqibb Company Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024350A1 (en) * 1995-12-27 1997-07-10 Janssen Pharmaceutica N.V. N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
WO1998028292A1 (en) * 1996-12-23 1998-07-02 Smithkline Beecham Corporation Novel piperidine containing compounds
WO2001062255A1 (en) * 2000-02-22 2001-08-30 Bristol-Myers Squibb Company Antiviral azaindole derivatives

Also Published As

Publication number Publication date
AR040230A1 (es) 2005-03-23
CA2487542A1 (en) 2004-05-27
CO5631440A2 (es) 2006-04-28
RU2004138565A (ru) 2005-07-20
RS53021B (sr) 2014-04-30
SI1513832T1 (sl) 2014-04-30
AU2003301958B2 (en) 2009-10-01
PT1513832E (pt) 2014-05-22
WO2004043337A2 (en) 2004-05-27
RU2323934C2 (ru) 2008-05-10
UA79470C2 (en) 2007-06-25
TWI310381B (en) 2009-06-01
CN100528866C (zh) 2009-08-19
WO2004043337A3 (en) 2004-11-11
JP2006507326A (ja) 2006-03-02
KR101001811B1 (ko) 2010-12-15
PL216388B1 (pl) 2014-03-31
TW200406397A (en) 2004-05-01
CL2003001087A1 (es) 2005-02-11
IS7546A (is) 2004-11-22
CA2487542C (en) 2011-09-27
BRPI0311541B1 (pt) 2018-04-24
IL165200A (en) 2011-01-31
PE20040526A1 (es) 2004-08-28
CN1671697A (zh) 2005-09-21
ES2460728T3 (es) 2014-05-14
IS2945B (is) 2016-05-15
DK1513832T3 (da) 2014-05-26
EP1513832B1 (en) 2014-03-05
NO20045064L (no) 2005-02-23
RS101304A (sr) 2006-10-27
NO329691B1 (no) 2010-11-29
PL373603A1 (en) 2005-09-05
NZ536661A (en) 2007-12-21
KR20050013558A (ko) 2005-02-04
US20040063744A1 (en) 2004-04-01
JP4446889B2 (ja) 2010-04-07
BR0311541A (pt) 2006-06-06
EP1513832A4 (en) 2010-03-10
MY139058A (en) 2009-08-28
GEP20074152B (en) 2007-07-10
HRP20041137A2 (en) 2005-06-30
EP1513832A2 (en) 2005-03-16
AU2003301958A1 (en) 2004-06-03
IL165200A0 (en) 2005-12-18
MXPA04011670A (es) 2005-03-07
ZA200409504B (en) 2006-05-31

Similar Documents

Publication Publication Date Title
HRP20041137B1 (hr) Indolni, azaindolni i srodni heterocikliäśni 4-alkenil piperidinski amidi
HRP20040317A2 (en) 1,8-naphthyridine derivatives as antidiabetics
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
SE0102616D0 (sv) Novel compounds
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
BR0315547A (pt) Derivados de quinolina como antagonistas de crth2
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
DE60010076D1 (de) Chinolinderivate als antibakterielle mittel
DE60140814D1 (de) N-phenyl-2-pyrimidine-amine derivatives
BRPI0514738A (pt) derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos
NO20090327L (no) Nye forbindelser 384
ATE353327T1 (de) Thiophenverbindungen als arzneimittel
TW200732323A (en) Organic compounds
SE0302116D0 (sv) Novel compounds
ATE440834T1 (de) Substituierte arylaminderivate und verwendungsverfahren
ATE380030T1 (de) Antivirale bicyclo-4.4.0-derivate
NO20070837L (no) Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer.
ECSP045469A (es) El uso de cianopirrolidinas sustituidas y preparaciones de combinacion que las contienen para tratar hiperlipidemia y enfermedades asociadas
AP1564A (en) Piperazinyl sulfonic acid derivatives, their pharmaceutical compositions and methods of use.
WO2003082861A3 (en) Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
SE0300092D0 (sv) Novel compounds
ATE534626T1 (de) Piperazinamidine als antivirale mittel
SE0300091D0 (sv) Novel compounds
TW200833697A (en) Spiro-piperidine derivatives
SE0301699D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20170419

Year of fee payment: 15

PPPP Transfer of rights

Owner name: VIIV HEALTHCARE UK (NO. 5) LIMITED, GB

PBON Lapse due to non-payment of renewal fee

Effective date: 20180430